Oct 15, 2009 | Free Republic
Sulfonylureas May Elevate Risk in MI Survivors (MI as in myocardial...
Four widely prescribed oral sulfonylurea drugs are associated with significantly increased risk of all-cause mortality compared with metformin in type 2 diabetic patients having a history of MI, according to a comprehensive Danish national cohort study.
Updated June 16, 2006 Sulfonylureas A class of drugs used in treating Type 2 diabetes.
Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green.
Springer Images Abstract CYP2C9 catalyzes the metabolism of important drugs such as phenytoin, S-warfarin, tolbutamide, losartan, and nonsteroidal anti-inflammatory drugs.
Metabolic fate of pitavastatin (NK-104), a new inhibitor of...
Metabolic fate of pitavastatin , a new inhibitor of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase.
[Genetic polymorphism of the CYP2C subfamily]
ChoiHyuk Abstract Cytochromes P450 are a superfamily of hemoproteins that metabolize various foreign compounds.
Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the...
NEW Abstract Several recent in-vitro data have revealed that CYP2C19, in addition to CYP2C9, is also involved in the 4-methylhydroxylation of tolbutamide.
Also on Topix